Miochol-E Drug Interactions
Currently displaying a list of 102 drugs known to interact with Miochol-E (acetylcholine ophthalmic).
- 96 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with Miochol-E
Note: Showing generic names only.
A
B
C
- carbinoxamine
- chlorcyclizine
- chlorpheniramine
- chlorpromazine
- clemastine
- clidinium
- clomipramine
- clozapine
- cyclizine
- cyclobenzaprine
- cyclopentolate ophthalmic
- cyproheptadine
D
- darifenacin
- desipramine
- dexbrompheniramine
- dexchlorpheniramine
- diclofenac ophthalmic
- dicyclomine
- dimenhydrinate
- diphenhydramine
- disopyramide
- doxepin
- doxepin topical
- doxylamine
F
G
H
I
K
L
M
- maprotiline
- meclizine
- mepenzolate
- mesoridazine
- methdilazine
- methotrimeprazine
- methscopolamine
- molindone
N
O
P
- perphenazine
- phenindamine
- pimozide
- procainamide
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- protriptyline
- pyrilamine
Q
R
S
T
- thiethylperazine
- thioridazine
- thiothixene
- tiotropium
- tolterodine
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimipramine
- tripelennamine
- triprolidine
- tropicamide ophthalmic
- trospium
U
Z
Miochol-E alcohol/food interactions
There is 1 alcohol/food interaction with Miochol-E (acetylcholine ophthalmic).
Miochol-E disease interactions
There is 1 disease interaction with Miochol-E (acetylcholine ophthalmic) which include:
Report options
QR code containing a link to this page
More about Miochol-E (acetylcholine ophthalmic)
- Miochol-E consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.